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Creation of variant forms has serious consequences in diagnostic, treatment strategies and the future vaccine 
development. Thus, the actual and future roles of the altered or emergent pathogens in the global pandemic of 
AIDS, Malaria, Flu and Ebola must be monitored in new molecular epidemiological studies. During the last 5 
years, we studied the genetic structure of several pathogens such as 1] malaria parasite showing that gene 
deletion, recombination can occur and lead to false RDT negative and to the creation of new antigens (hybrid 
parasites); 2] in HIV,  our findings indicate a shift in the virus population circulating over time in Mali. Those 
observations are suggesting that a vaccine development against those pathogens such Plasmodium falciparum 
parasite and HIV will be a challenge. Our approach that is to target pieces of antigens within a genome which 
must be well conserved across the specie and immunogenic enough in boosting the immune response. Four 
steps were identified in that approach which are: 1] Genome mining using computational and experimental tools 
to identify genes that encode proteins with promising vaccine antigens properties, 2] use of the 
Immunoinformatics tools to map protein sequences for short, linear putative T-cell epitopes CTL/ T helper, 3] 
then candidates are synthesized as peptides and evaluated for HLA binding and antigenicity (in vitro evaluation) 
and then 4] Prototype epitope-based vaccines are evaluated for immunogenicity in human Host (in vivo 
evaluation). Our laboratory has partnered with the GAIA foundation to test this approach in Mali.  
 
